Evidence map›Paper›PMID 37552409›Full record

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2024

A deep learning model for accurately predicting cancer-specific survival in patients with primary bone sarcoma of the extremity: a population-based study.

Debin Cheng, Dong Liu, Xian Li, Zhenzhou Mi, Zhao Zhang, Weidong Tao, Jingyi Dang, Dongze Zhu, Jun Fu, Hongbin Fan

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Debin Cheng *Department of Orthopaedics, Xijing Hospital, The Fourth Military Medical University, Xi'an, 710032, China.
Dong Liu *Department of Orthopaedics, Xijing Hospital, The Fourth Military Medical University, Xi'an, 710032, China.
Xian Li *Department of Orthopaedics, Shenzhen University General Hospital, Shenzhen, 518052, China.
Zhenzhou MiDepartment of Orthopaedics, Xijing Hospital, The Fourth Military Medical University, Xi'an, 710032, China.
Zhao ZhangDepartment of Orthopaedics, Xijing Hospital, The Fourth Military Medical University, Xi'an, 710032, China.
Weidong TaoDepartment of Orthopaedics, Xijing Hospital, The Fourth Military Medical University, Xi'an, 710032, China.
Jingyi DangDepartment of Orthopaedics, Xijing Hospital, The Fourth Military Medical University, Xi'an, 710032, China.
Dongze ZhuDepartment of Orthopaedics, Xijing Hospital, The Fourth Military Medical University, Xi'an, 710032, China.
Jun FuDepartment of Orthopaedics, Xijing Hospital, The Fourth Military Medical University, Xi'an, 710032, China.
Hongbin FanDepartment of Orthopaedics, Xijing Hospital, The Fourth Military Medical University, Xi'an, 710032, China. fanhb@fmmu.edu.cn.ORCID http://orcid.org/0000-0002-7656-9530
Xijing Hospital · CNShenzhen University · CN

Funding

International Science and Technology Cooperation Program of Shanxi Province No.2023-GHZD-25National Natural Science Foundation of China No. 31971272Sanming Project of Medicine in Shenzhen No.SZSM201911011
6 · The paper itself

Abstract

purposePrimary bone and joint sarcomas of the long bone are relatively rare neoplasms with poor prognosis. An efficient clinical tool that can accurately predict patient prognosis is not available. The current study aimed to use deep learning algorithms to develop a prediction model for the prognosis of patients with long bone sarcoma.

methodsData of patients with long bone sarcoma in the extremities was collected from the Surveillance, Epidemiology, and End Results Program database from 2004 to 2014. Univariate and multivariate analyses were performed to select possible prediction features. DeepSurv, a deep learning model, was constructed for predicting cancer-specific survival rates. In addition, the classical cox proportional hazards model was established for comparison. The predictive accuracy of our models was assessed using the C-index, Integrated Brier Score, receiver operating characteristic curve, and calibration curve.

resultsAge, tumor extension, histological grade, tumor size, surgery, and distant metastasis were associated with cancer-specific survival in patients with long bone sarcoma. According to loss function values, our models converged successfully and effectively learned the survival data of the training cohort. Based on the C-index, area under the curve, calibration curve, and Integrated Brier Score, the deep learning model was more accurate and flexible in predicting survival rates than the cox proportional hazards model.

conclusionA deep learning model for predicting the survival probability of patients with long bone sarcoma was constructed and validated. It is more accurate and flexible in predicting prognosis than the classical CoxPH model.

Indexed as

Bone NeoplasmsDeep LearningOsteosarcomaSarcomaExtremitiesHumansNomogramsPrognosisBone sarcomaCancer-specific survivalDeep learningDeepSurvLong bonePrognosisPrognosis predictionSEER database

Identifiers

PMID37552409
OpenAlexW4385665070

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.